Fears are growing in Mayo over US President Donald Trump’s planned announcement next Wednesday in respect of placing tariffs ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

The company shed its FSD Pharma identity last year as it positions its alcohol metabolism and multiple sclerosis treatments ...

Envestnet Portfolio Solutions Inc. reduced its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Some drugmakers are taking the unusual step of sending more medicines by air to the U.S., two executives and two logistics ...

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, details the Biosecure Act, including the ways pharma ...

Teasing tariffs on pharmaceuticals, US President Donald Trump said a lot are made in Ireland, but added that "we love Ireland ...

We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...